Solved

Passage Hemophilia B Is a Blood Clotting Disorder Caused by a a Factor

Question 17

Multiple Choice

Passage
Hemophilia B is a blood clotting disorder caused by a factor IX (FIX) deficiency.  FIX is a 57-kDa, vitamin K-dependent protease that activates factor X, leading to the conversion of prothrombin to thrombin for propagation of the clotting cascade.  Activated FIX has two major domains:  a γ-carboxyglutamic acid domain and a serine protease domain.  The γ-carboxyglutamic acid domain participates in the oxidation of vitamin K using metallic cofactors, as shown in Figure 1.
Passage Hemophilia B is a blood clotting disorder caused by a factor IX (FIX)  deficiency.  FIX is a 57-kDa, vitamin K-dependent protease that activates factor X, leading to the conversion of prothrombin to thrombin for propagation of the clotting cascade.  Activated FIX has two major domains:  a γ-carboxyglutamic acid domain and a serine protease domain.  The γ-carboxyglutamic acid domain participates in the oxidation of vitamin K using metallic cofactors, as shown in Figure 1.    <strong>Figure 1</strong>  Oxidation of vitamin KTo further analyze the γ-carboxyglutamic acid-rich domain of FIX, an analogous synthetic peptide composed of matching residues 1 through 49 on FIX was evaluated by proton nuclear magnetic resonance (NMR)  spectroscopy.  Analysis of the proton chemical shift before the addition of metal ions suggested that the synthetic peptide contained normal structural elements.  Large chemical shifts were observed after the addition of calcium and beryllium, as shown in Figure 2.    <strong>Figure 2</strong>  Results of NMR spectroscopy (tetramethylsilane [TMS] peak has been removed) The synthetic analog was then placed in solution with vitamin K hydroquinone and cofactors required for vitamin K oxidation.  The oxidation products of vitamin K in Reactions 1 and 2 were collected and evaluated under high-performance liquid chromatography (HPLC)  using hexane as the mobile phase.  Analysis demonstrated cis and trans isomers of vitamin K<sub>1</sub> and a trans-epoxy vitamin K<sub>1</sub>, as shown in Figure 3.    <strong>Figure 3</strong>  Results of HPLC separation Adapted from Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem. 1995. -In Reaction 1, what hybridization state changes do the methylated carbon atom in the ringed structure of vitamin K hydroquinone and the oxygen atom involved in epoxide formation undergo? A) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom B) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp to sp<sup>2</sup> for the oxygen atom C) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>2</sup> for the oxygen atom D) sp to sp<sup>2</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom Figure 1  Oxidation of vitamin KTo further analyze the γ-carboxyglutamic acid-rich domain of FIX, an analogous synthetic peptide composed of matching residues 1 through 49 on FIX was evaluated by proton nuclear magnetic resonance (NMR) spectroscopy.  Analysis of the proton chemical shift before the addition of metal ions suggested that the synthetic peptide contained normal structural elements.  Large chemical shifts were observed after the addition of calcium and beryllium, as shown in Figure 2.
Passage Hemophilia B is a blood clotting disorder caused by a factor IX (FIX)  deficiency.  FIX is a 57-kDa, vitamin K-dependent protease that activates factor X, leading to the conversion of prothrombin to thrombin for propagation of the clotting cascade.  Activated FIX has two major domains:  a γ-carboxyglutamic acid domain and a serine protease domain.  The γ-carboxyglutamic acid domain participates in the oxidation of vitamin K using metallic cofactors, as shown in Figure 1.    <strong>Figure 1</strong>  Oxidation of vitamin KTo further analyze the γ-carboxyglutamic acid-rich domain of FIX, an analogous synthetic peptide composed of matching residues 1 through 49 on FIX was evaluated by proton nuclear magnetic resonance (NMR)  spectroscopy.  Analysis of the proton chemical shift before the addition of metal ions suggested that the synthetic peptide contained normal structural elements.  Large chemical shifts were observed after the addition of calcium and beryllium, as shown in Figure 2.    <strong>Figure 2</strong>  Results of NMR spectroscopy (tetramethylsilane [TMS] peak has been removed) The synthetic analog was then placed in solution with vitamin K hydroquinone and cofactors required for vitamin K oxidation.  The oxidation products of vitamin K in Reactions 1 and 2 were collected and evaluated under high-performance liquid chromatography (HPLC)  using hexane as the mobile phase.  Analysis demonstrated cis and trans isomers of vitamin K<sub>1</sub> and a trans-epoxy vitamin K<sub>1</sub>, as shown in Figure 3.    <strong>Figure 3</strong>  Results of HPLC separation Adapted from Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem. 1995. -In Reaction 1, what hybridization state changes do the methylated carbon atom in the ringed structure of vitamin K hydroquinone and the oxygen atom involved in epoxide formation undergo? A) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom B) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp to sp<sup>2</sup> for the oxygen atom C) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>2</sup> for the oxygen atom D) sp to sp<sup>2</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom Figure 2  Results of NMR spectroscopy (tetramethylsilane [TMS] peak has been removed) The synthetic analog was then placed in solution with vitamin K hydroquinone and cofactors required for vitamin K oxidation.  The oxidation products of vitamin K in Reactions 1 and 2 were collected and evaluated under high-performance liquid chromatography (HPLC) using hexane as the mobile phase.  Analysis demonstrated cis and trans isomers of vitamin K1 and a trans-epoxy vitamin K1, as shown in Figure 3.
Passage Hemophilia B is a blood clotting disorder caused by a factor IX (FIX)  deficiency.  FIX is a 57-kDa, vitamin K-dependent protease that activates factor X, leading to the conversion of prothrombin to thrombin for propagation of the clotting cascade.  Activated FIX has two major domains:  a γ-carboxyglutamic acid domain and a serine protease domain.  The γ-carboxyglutamic acid domain participates in the oxidation of vitamin K using metallic cofactors, as shown in Figure 1.    <strong>Figure 1</strong>  Oxidation of vitamin KTo further analyze the γ-carboxyglutamic acid-rich domain of FIX, an analogous synthetic peptide composed of matching residues 1 through 49 on FIX was evaluated by proton nuclear magnetic resonance (NMR)  spectroscopy.  Analysis of the proton chemical shift before the addition of metal ions suggested that the synthetic peptide contained normal structural elements.  Large chemical shifts were observed after the addition of calcium and beryllium, as shown in Figure 2.    <strong>Figure 2</strong>  Results of NMR spectroscopy (tetramethylsilane [TMS] peak has been removed) The synthetic analog was then placed in solution with vitamin K hydroquinone and cofactors required for vitamin K oxidation.  The oxidation products of vitamin K in Reactions 1 and 2 were collected and evaluated under high-performance liquid chromatography (HPLC)  using hexane as the mobile phase.  Analysis demonstrated cis and trans isomers of vitamin K<sub>1</sub> and a trans-epoxy vitamin K<sub>1</sub>, as shown in Figure 3.    <strong>Figure 3</strong>  Results of HPLC separation Adapted from Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem. 1995. -In Reaction 1, what hybridization state changes do the methylated carbon atom in the ringed structure of vitamin K hydroquinone and the oxygen atom involved in epoxide formation undergo? A) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom B) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp to sp<sup>2</sup> for the oxygen atom C) sp<sup>2</sup> to sp<sup>3</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>2</sup> for the oxygen atom D) sp to sp<sup>2</sup> for the methylated carbon and sp<sup>2</sup> to sp<sup>3</sup> for the oxygen atom Figure 3  Results of HPLC separation
Adapted from Freedman SJ, Furie BC, Furie B, Baleja JD. Structure of the metal-free gamma-carboxyglutamic acid-rich membrane binding region of factor IX by two-dimensional NMR spectroscopy. J Biol Chem. 1995.
-In Reaction 1, what hybridization state changes do the methylated carbon atom in the ringed structure of vitamin K hydroquinone and the oxygen atom involved in epoxide formation undergo?


A) sp2 to sp3 for the methylated carbon and sp2 to sp3 for the oxygen atom
B) sp2 to sp3 for the methylated carbon and sp to sp2 for the oxygen atom
C) sp2 to sp3 for the methylated carbon and sp2 to sp2 for the oxygen atom
D) sp to sp2 for the methylated carbon and sp2 to sp3 for the oxygen atom

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents